Search results for: psoriasis

Janus Kinase Inhibitors Represent New Tool to Slow Rheumatoid Arthritis

Gretchen Henkel | July 1, 2014

Physicians at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco report on studies about JAK inhibitors as targeted immunomodulators and disease-modifying therapies in RA

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP | June 1, 2014

Legislative news on biosimilars, safety warning on epidural corticosteroid injections, and other drug updates rheumatologists need to know

What’s New in Inflammatory Arthritis?

Thomas R. Collins | June 1, 2014

Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair

Skin Oils Act as Natural, Tissue-Specific Autoantigens

Lara C. Pullen, PhD | May 2, 2014

The results of this study identify natural lipids present in the skin that augment and inhibit human T cell response, supporting the idea that lipids are T cell antigens.

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP | May 1, 2014

Information on oral anticoagulant apixaban, apremilast for active psoriatic arthritis, hyaluronic acid and methotrexate injections, and drug safety updates rheumatologists need to know

Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

Atul Deodhar, MD | May 1, 2014

New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

Treating Early-Stage Spondyloarthritis May Prevent Disease Progression, Say Researchers at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff | April 2, 2014

Therapy with tumor necrosis factor inhibitors, nonsteroidal antiinflammatory drugs, ustekinumab in early stages of osteitis may halt molecular switching to bone-forming phenotype characteristic of SpA